At Rophevac, our Research & Development is at the heart of everything we do. We are committed to pioneering innovative genomic solutions that transform healthcare and improve patient outcomes across India and globally.
Harnessing artificial intelligence and machine learning for genomic insights
Machine learning on multi-omic datasets for target identification, protein structure prediction, and in silico validation.
Learn MoreAutomated variant classification using VarMiner and OncoMiner platforms with ACMG/AMP guidelines.
Learn MoreMulti-omic integration and predictive biomarkers for treatment response and disease progression.
Learn MoreAI-powered image analysis with quantitative continuous scoring for biomarker assessment and tissue analysis.
Learn MorePatient recruitment, adaptive trial designs, and real-time monitoring using artificial intelligence.
Learn MorePharmacogenomics and cancer treatment selection using AI-driven molecular profiling.
Learn MoreScientific literature mining and clinical note analysis for evidence extraction and phenotype identification.
Learn MoreUnified data platform, cloud computing, machine learning platforms, and bioinformatics tools.
Learn MoreResponsible AI principles, data privacy, and model validation ensuring transparency and fairness.
Learn MoreRophevac's R&D operations are focused on advancing genetic testing technologies, developing precision medicine solutions, and creating next-generation diagnostic tools that enable early disease detection, accurate diagnosis, and personalized treatment strategies.
Scientific Publications
Patents Filed
Tests Performed Annually
Revenue in R&D